Elevance Health Inc [ELV] stock is trading at $309.6, down -0.13%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELV shares have gain 4.80% over the last week, with a monthly amount glided 4.38%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on July 21, 2025, when Argus downgraded its rating to a Hold. Previously, Leerink Partners downgraded its rating to Market Perform on July 18, 2025, and kept the price target unchanged to $310. On April 15, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $529 on the stock. Argus upgraded its rating to a Buy but stick to its price target of $450 on March 17, 2025. Stephens downgraded its rating to a Equal-Weight and reduced its price target to $440 on January 22, 2025. Argus downgraded its rating to Hold for this stock on October 18, 2024. In a note dated July 18, 2024, BofA Securities downgraded an Neutral rating on this stock and revised its target price from $646 to $530.
Elevance Health Inc [ELV] stock has fluctuated between $273.71 and $567.26 over the past year. Currently, Wall Street analysts expect the stock to reach $482.5 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $309.6 at the most recent close of the market. An investor can expect a potential return of 55.85% based on the average ELV price forecast.
Analyzing the ELV fundamentals
Elevance Health Inc [NYSE:ELV] reported sales of 189.25B for the trailing twelve months, which represents a growth of 14.04%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 307.60 points at the first support level, and at 305.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 312.62, and for the 2nd resistance point, it is at 315.63.
Ratios To Look Out For
For context, Elevance Health Inc’s Current Ratio is 1.44. Considering the valuation of this stock, the price to sales ratio is 0.37, the price to book ratio is 1.59 and price to earnings (TTM) ratio is 13.18.
Transactions by insiders
Recent insider trading involved DeVore Susan D., Director, that happened on Aug 19 ’25 when 1200.0 shares were purchased. President and CEO, BOUDREAUX GAIL completed a deal on Jul 18 ’25 to buy 8500.0 shares. Meanwhile, EVP & CFO Kaye Mark sold 4588.0 shares on Apr 24 ’25.
